Bubbling therapy for dysfunctional breathing in difficult to treat asthma - a pilot study

Bubbling therapy for dysfunctional breathing in difficult to treat asthma - a pilot study - Bubble study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON42399

Enrollment

Registered

2015-08-27

Start date

2016-04-04

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma dysfunctional breathing

Interventions

Group A: Usual care. Optimal treatment of asthma Group B: As group A and Consultation of the speech pathologist and bubbling therapy

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: • Difficult to treat asthma And either/or o Chronic hypocapnia (pCO2 4 AND • No anatomical or mechanical abnormalities in the naso-oro-hypo-pharyngeal tract

Exclusion criteria

Exclusion criteria: • Current smoking or more than 10 PY in history • Recent exacerbation of asthma or airway infection ( 50 ppb *

Design outcomes

Primary

Measure	Time frame
Primary endpoint is the percentage of patients with a clinically relevant improvement in asthma control (ACQ) after treatment (week 6), defined as ΔACQ >0.5.	—

Secondary

Measure	Time frame
Secondary endpoints are asthma quality of life (AQLQ), lung function (FEV1), use of rescue inhalation medication, FeNO, Nijmegen hyperventilation Score, Borg score for dyspnea and the vocal handicap index (VHI).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)